Autoimmune Disease Diagnosis Market

Report Overview

The global autoimmune disease diagnosis market was pegged at US$ 9.79 billion in 2020 and is expected to witness a CAGR of 8.6% during the forecast period.

Market Fundamentals

Autoimmune disease causes the immune system to produce antibodies that attack normal body tissues. In an autoimmune disease, the immune system mistakes a part of the person's body as foreign and releases proteins such as autoantibodies that attack healthy cells. These diseases cause weakening of bodily function and in some cases it can prove life-threatening. There are more than 150 known autoimmune diseases. Some autoimmune diseases target only one organ and are known as localized autoimmune disease. Whereas, other diseases, such as systemic lupus erythematosus affect the whole body and are known as systemic autoimmune diseases. Most of these diseases have no cure. Some require lifelong treatment to ease symptoms. Therefore, diagnosis of these diseases is important for initiating the right treatment.

[694523]

Market Dynamics

Factors driving the growth of autoimmune disease diagnosis market include the rising prevalence of autoimmune diseases, their growing awareness, and increasing diagnosis. Moreover, increasing number of research studies and incessant launch of advanced products are also playing a pivotal role in propelling the growth of global autoimmune disease diagnosis market. However, high capital investments needed for setting a diagnostic laboratory and dearth of skilled professionals to conduct these tests are some of the factors hindering the autoimmune disease diagnosis market growth to a certain extent.

Market Ecosystem

The global autoimmune disease diagnosis market has been analyzed from four perspectives: Product, Type, Test Type, and Region.

Autoimmune Disease Diagnosis Market by Product

[75734532]

Based on product, the autoimmune disease diagnosis market has been segmented into instruments and consumables & assay kits. Consumables & assay kits segment held the largest share of the autoimmune disease diagnosis market in 2020. The rising prevalence of autoimmune diseases and growing number of tests are some of the key factors contributing to the growth of consumables and assay kits segment.

Autoimmune Disease Diagnosis Market by Type

Based on type, the market has been segmented into localized autoimmune disease diagnostics and systemic autoimmune disease diagnostics. Localized autoimmune disease diagnostics segment is further bifurcated into type 1 diabetes, multiple sclerosis, idiopathic thrombocytopenic purpura, Hashimoto's thyroiditis, and others (such as Addison's disease, grave's disease, myasthenia gravis, etc.). Similarly, systemic autoimmune disease diagnostics is categorized into rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus (SLE), and others (scleroderma, Sjogren's syndrome, antiphospholipid antibody syndromes, etc.). Localized autoimmune disease diagnostics dominated the autoimmune disease diagnosis market in terms of revenue in 2020. Factors driving the growth of this segment include the rising incidence of localized autoimmune diseases such as type 1 diabetes, and multiple sclerosis; and growing patient awareness for getting tested for these diseases.

Autoimmune Disease Diagnosis Market by Test Type

Based on test type, the market has been segmented into routine laboratory tests, autoantibodies & immunologic tests, inflammatory markers, and other tests. Routine laboratory tests segment held the largest market share in 2020. The rising number of routine laboratory tests for diagnosis of autoimmune diseases is one of the key factors driving the growth of the segment.

Autoimmune Disease Diagnosis Market by Region

Regionally, the global autoimmune disease diagnosis market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America dominated the market for autoimmune disease diagnosis holding the largest market share in 2020. The rising incidence of autoimmune disease in this region is one of the major factors fueling the growth of this market. According to the National Institutes of Health, around 23.5 million Americans i.e. more than 7% of the population suffer from an autoimmune disease. Moreover, the growing awareness for getting tested for these diseases, greater healthcare expenditure, and the favorable reimbursement policies are anticipated to boost the market growth during the projected period.

Competitive Landscape

Some of the prominent players operating in the global autoimmune disease diagnosis market includes:-

• Thermo Fisher Scientific Inc
• Siemens Healthcare Private Limited
• Abbott
• Trinity Biotech Plc
• F. Hoffmann-La Roche Ltd
• Bio-Rad Laboratories, Inc
• Beckman Coulter, Inc
• BioMérieux SA
• Euroimmun Medizinische Labordiagnostika AG (a PerkinElmer company)
• Inova Diagnostics, Inc., among others.

Strategic Developments

• In September 2020, Exagen Inc. launched AVISEV asculitis AAV, a test aiding in the detection of ANCA-Associated Vasculitis (AAV). It is a testing panel of individual analytes which provides physicians with rapid and reliable results and monitoring of ANCA-associated vasculitis (AAV).
• In October 2019, DxTerity Diagnostics launched the IFN-1 Test for determining a systemic lupus erythematosus patient's type 1 interferon status and the risk of progressing to lupus nephritis.

Frequently Asked Questions About This Report